Germany Diabetes Drugs and Devices Market Size- By Monitoring Devices, By Management Devices- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Germany Diabetes Drugs and Devices Market Introduction and Overview

According to SPER Market Research, 'Germany Diabetes Drugs and Devices Market Size- By Monitoring Devices, By Management Devices- Regional Outlook, Competitive Strategies and Segment Forecast to 2033. the Germany Diabetes Drugs and Devices Market is estimated to reach USD 8.98 billion by 2033 with a CAGR of 4.61%.

The Diabetes Drugs and Devices market is a specialist section of the healthcare industry that focuses on diabetes management solutions. This market encompasses a wide range of antidiabetic pharmaceuticals, from basic insulin therapy to newer classes of medications including GLP-1 receptor agonists and SGLT2 inhibitors, all of which are aimed to help control blood sugar levels via different methods.

COVID-19 changed the market dynamics of diabetic medications and devices in Germany, hastening the implementation of digital health technologies and home-care options. The demand for social isolation and fewer hospital visits drove the usage of remote monitoring equipment and telemedicine consultations. This transition not only contributed to the continuity of care for diabetic patients, but it also fuelled innovation in diabetes technology.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Monitoring Devices, By Management Devices

Regions covered North Rhine-Westphalia, Bavaria, Baden-Wurttemberg, Saxony, Hesse, Rest of Germany

Companies Covered Abbott Diabetes Care, Roche Diabetes Care, DexCom Inc., Medtronic PLC, Insulet Corporation, ARKRAY Inc., Ascensia Diabetes Care, AgaMatrix, Bionime Corporation, Novo Nordisk, Others.

Germany Diabetes Drugs and Devices Market Segmentation:

By Monitoring Devices: Based on the Monitoring Devices, Germany Diabetes Drugs and Devices Market is segmented as; Self-Monitoring Blood Glucose, Continuous Glucose Monitoring.

By Management Devices: Based on the Management Devices, Germany Diabetes Drugs and Devices Market is segmented as; Insulin Pumps, Insulin Disposable Pens, Insulin Syringes, Cartridges in Reusable Pens, Jet Injectors.

By Region: This research also includes data for North Rhine-Westphalia, Bavaria, Baden-Wurttemberg, Saxony, Hesse, Rest of Germany.

Product Code: MEDE2436

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Germany Diabetes Drugs and Devices Market.

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Germany Diabetes Drugs and Devices Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Germany Diabetes Drugs and Devices Market

7. Germany Diabetes Drugs and Devices Market, By Monitoring Devices (USD Million) 2020-2033

7.1. Germany Diabetes Drugs and Devices Market Size, Share and Forecast, By Monitoring Devices, 2020-2026
7.2. Germany Diabetes Drugs and Devices Market Size, Share and Forecast, By Monitoring Devices, 2027-2033
7.3. Self-Monitoring Blood Glucose
7.4. Continuous Glucose Monitoring

8. Germany Diabetes Drugs and Devices Market, By Management Devices (USD Million) 2020-2033

8.1. Germany Diabetes Drugs and Devices Market Size, Share and Forecast, By Management Devices, 2020-2026
8.2. Germany Diabetes Drugs and Devices Market Size, Share and Forecast, By Management Devices, 2027-2033
8.3. Insulin Pumps
8.4. Insulin Disposable Pens
8.5. Insulin Syringes
8.6. Cartridges in Reusable Pens
8.7. Jet Injectors

9. Germany Diabetes Drugs and Devices Market Forecast, 2020-2033 (USD Million)

9.1. Germany Diabetes Drugs and Devices Market Size and Market Share

10. Germany Diabetes Drugs and Devices Market, By Region, 2020-2033 (USD Million)

10.1. Germany Diabetes Drugs and Devices Market Size and Market Share By Region (2020-2026)
10.2. Germany Diabetes Drugs and Devices Market Size and Market Share By Region (2027-2033)
- 10.2.1. North Rhine-Westphalia
- 10.2.2. Bavaria
- 10.2.3. Baden-Wurttemberg
- 10.2.4. Saxony
- 10.2.5. Hesse
- 10.2.6. Rest of Germany

11. Company Profile

11.1 . Abbott Diabetes Care
- 11.1.1. Company details
- 11.1.2. Financial outlook
- 11.1.3. Product summary
- 11.1.4. Recent developments
11.2. Roche Diabetes Care
- 11.2.1. Company details
- 11.2.2. Financial outlook
- 11.2.3. Product summary
- 11.2.4. Recent developments
11.3. DexCom Inc.
- 11.3.1. Company details
- 11.3.2. Financial outlook
- 11.3.3. Product summary
- 11.3.4. Recent developments
11.4. Medtronic PLC
- 11.4.1. Company details
- 11.4.2. Financial outlook
- 11.4.3. Product summary
- 11.4.4. Recent developments
11.5. Insulet Corporation
- 11.5.1. Company details
- 11.5.2. Financial outlook
- 11.5.3. Product summary
- 11.5.4. Recent developments
11.6. ARKRAY Inc.
- 11.6.1. Company details
- 11.6.2. Financial outlook
- 11.6.3. Product summary
- 11.6.4. Recent developments
11.7. Ascensia Diabetes Care
- 11.7.1. Company details
- 11.7.2. Financial outlook
- 11.7.3. Product summary
- 11.7.4. Recent developments
11.8. AgaMatrix
- 11.8.1. Company details
- 11.8.2. Financial outlook
- 11.8.3. Product summary
- 11.8.4. Recent developments
11.9. Bionime Corporation
- 11.9.1. Company details
- 11.9.2. Financial outlook
- 11.9.3. Product summary
- 11.9.4. Recent developments
11.10. Novo Nordisk
- 11.10.1. Company details
- 11.10.2. Financial outlook
- 11.10.3. Product summary
- 11.10.4. Recent developments
11.11. Others